| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Private Rented Sector S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł3.14 |
| 52 Week High | zł11.60 |
| 52 Week Low | zł2.00 |
| Beta | 2.39 |
| 11 Month Change | -24.52% |
| 3 Month Change | n/a |
| 1 Year Change | 37.72% |
| 33 Year Change | 63.54% |
| 5 Year Change | 88.02% |
| Change since IPO | -98.22% |
Recent News & Updates
Recent updates
Shareholder Returns
| RNT | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | 1.9% | -4.1% | -1.2% |
| 1Y | 37.7% | -5.1% | 3.2% |
Return vs Industry: RNT exceeded the Polish Medical Equipment industry which returned -1.9% over the past year.
Return vs Market: RNT exceeded the Polish Market which returned 5.4% over the past year.
Price Volatility
| RNT volatility | |
|---|---|
| RNT Average Weekly Movement | 21.9% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: RNT's share price has been volatile over the past 3 months compared to the Polish market.
Volatility Over Time: RNT's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jakuba Suchanek | www.medical-isotope.com |
Private Rented Sector S.A. develops and commercializes medical isotopes in Poland. The company offers Technetium-99m, a medical isotope for deployment using standard research and commercial reactors. The company was formerly known as Perma-Fix Medical S.A. and changed its name to Private Rented Sector S.A. in March 2023.
Private Rented Sector S.A. Fundamentals Summary
| RNT fundamental statistics | |
|---|---|
| Market cap | zł4.15m |
| Earnings (TTM) | -zł67.13k |
| Revenue (TTM) | zł100.00k |
41.5x
P/S Ratio-61.8x
P/E RatioIs RNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RNT income statement (TTM) | |
|---|---|
| Revenue | zł100.00k |
| Cost of Revenue | zł0 |
| Gross Profit | zł100.00k |
| Other Expenses | zł167.13k |
| Earnings | -zł67.13k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | -0.051 |
| Gross Margin | 100.00% |
| Net Profit Margin | -67.13% |
| Debt/Equity Ratio | 0% |
How did RNT perform over the long term?
See historical performance and comparison